LivePerson (LPSN) Investors Case

The plaintiff has voluntarily dismissed the case, ending the lawsuit.

E.D. New York

Court

1:23-cv-3078

Case number

05/10/2022

Class period Start

03/16/2023

Class period End

06/23/2023

Lead Plaintiff motion deadline

LivePerson disclosed that WildHealth, the Company's subsidiary, received a notice that Medicare was suspending reimbursements for services.
$LPSN price declined 57.72%, damaging investors.
Investors suspect LivePerson, its Leaders & Service Providers of negligence or failure to properly disclose material information.

On March 15, 2023, LivePerson (LPSN) disclosed that WildHealth, the Company's subsidiary, received a notice that Medicare was suspending reimbursements for services rendered under the Medicare demonstration program pending further review.

As a result, LivePerson elected to take a reserve for revenue associated with such services in the Q4 of 2022 for which payment has not yet been collected.
LivePerson further disclosed that had the Company recognized revenues associated with services delivered under the program during the fourth quarter of fiscal 2022, its revenue would have been within the previous guidance ranges for the fourth quarter and full year.

On this news, the $LPSN price declined 57.72%, damaging investors.

Taking all facts into account, Investors may have reasons to suspect LivePerson, its Leaders & Service Providers of negligence or failure to properly disclose material information.

Case Status

Voluntary Dismissed

Alleged Offence

Mismanagement,

Misleading Statements,

Failure to Disclose,

Malpractice,

Negligence,

Omissions

Suspected Party

Directors,

Management,

Service Provider

Security Type

Stocks

Trade Direction

Long

Shock Event Date

03/15/2023

Lead Plaintiff Deadline

06/23/2023